background medical nutrition therapy is recognized as an important treatment option in type 2 diabetesmost guidelines recommend eating a diet with a high intake of fiberrich food including fruitthis is based on the many positive effects of fruit on human healthhowever some health professionals have concerns that fruit intake has a negative impact on glycemic control and therefore recommend restricting the fruit intakewe found no studies addressing this important clinical questionthe objective was to investigate whether an advice to reduce the intake of fruit to patients with type 2 diabetes affects hba1c bodyweight waist circumference and fruit intakemethods this was an open randomized controlled trial with two parallel groupsthe primary outcome was a change in hba1c during 12 weeks of interventionparticipants were randomized to one of two interventions medical nutrition therapy  advice to consume at least two pieces of fruit a day highfruit or medical nutrition therapy  advice to consume no more than two pieces of fruit a day lowfruitall participants had two consultations with a registered dietitianfruit intake was selfreported using 3day fruit records and dietary recallsall assessments were made by the intention to treat principleresults the study population consisted of 63 men and women with newly diagnosed type 2 diabetesall patients completed the trialthe highfruit group increased fruit intake with 125 grams ci 95 78 to 172 and the lowfruit group reduced intake with 51 grams ci 95 18 to 83hba1c decreased in both groups with no difference between the groups diff 019 ci 95 023 to 062both groups reduced body weight and waist circumference however there was no difference between the groupsconclusions a recommendation to reduce fruit intake as part of standard medical nutrition therapy in overweight patients with newly diagnosed type 2 diabetes resulted in eating less fruitit had however no effect on hba1c weight loss or waist circumferencewe recommend that the intake of fruit should not be restricted in patients with type 2 diabetestrial registration httpwwwclinicaltrialsgov identifier nct01010594